Profile of the hepatocellular carcinoma in patients with diagnosis of chronic C hepatitis [Abstract in English]
Autor(a) principal: | |
---|---|
Data de Publicação: | 2007 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Scientia Medica (Porto Alegre. Online) |
Texto Completo: | https://revistaseletronicas.pucrs.br/scientiamedica/article/view/1614 |
Resumo: | Aims: To determine the profile of the patients with diagnosis of hepatocellular carcinoma (HCC) and chronic C hepatitis at HSL-PUCRS. Methods: Transversal study with data obtained from medical records. In a 24 months period the medical records of all patients who had alfa-fetoproteins dosed at HSL clinical pathology laboratory were reviewed. All those who had the diagnosis of HCC and HCV infection were included. Results: 28 cases of HCC associated with HCV infection were identified. All patients had signs of chronic hepatic disease. 28.5%, however, were asymptomatic at the time of diagnosis. A non invasive criterion for diagnosis was used in 64.3% of the patients. The serum dosage of alfa-fetoproteins was higher than 400 ng/mL in 67.8% of the patients and the combination of two image methods was used in 60.7%. 78.5% of the tumors were nodular and 57.1% located at the right lobe. In 25% the diagnosis was done at an early stage, with possibility of curative treatment. In half the patients no specific tumor treatment was indicated because they were staged as advanced disease. Conclusions: The profile of the patients with HCC and chronic HCV is similar to other occidental populations described at the literature. Two variables differed from the literature: the high rate of HCC diagnosed at an early stage and with possibility of curative treatment and the greater percentage of cases diagnosed in asymptomatic patients. KEY WORDS: HEPATOCELLULAR, CARCINOMA; HEPATITIS C, CHRONIC/epidemiology; ALFA-FETOPROTEINS. |
id |
PUC_RS-25_65b21449132fb01779fc4c6016e9382a |
---|---|
oai_identifier_str |
oai:ojs.revistaseletronicas.pucrs.br:article/1614 |
network_acronym_str |
PUC_RS-25 |
network_name_str |
Scientia Medica (Porto Alegre. Online) |
repository_id_str |
|
spelling |
Profile of the hepatocellular carcinoma in patients with diagnosis of chronic C hepatitis [Abstract in English]Perfil do carcinoma hepatocelular em pacientes portadores de hepatopatia crônica pelo vírus CCARCINOMA HEPATOCELULARHEPATITE C CRÔNICAEPIDEMIOLOGIAALFA-FETOPROTEÍNAS.Aims: To determine the profile of the patients with diagnosis of hepatocellular carcinoma (HCC) and chronic C hepatitis at HSL-PUCRS. Methods: Transversal study with data obtained from medical records. In a 24 months period the medical records of all patients who had alfa-fetoproteins dosed at HSL clinical pathology laboratory were reviewed. All those who had the diagnosis of HCC and HCV infection were included. Results: 28 cases of HCC associated with HCV infection were identified. All patients had signs of chronic hepatic disease. 28.5%, however, were asymptomatic at the time of diagnosis. A non invasive criterion for diagnosis was used in 64.3% of the patients. The serum dosage of alfa-fetoproteins was higher than 400 ng/mL in 67.8% of the patients and the combination of two image methods was used in 60.7%. 78.5% of the tumors were nodular and 57.1% located at the right lobe. In 25% the diagnosis was done at an early stage, with possibility of curative treatment. In half the patients no specific tumor treatment was indicated because they were staged as advanced disease. Conclusions: The profile of the patients with HCC and chronic HCV is similar to other occidental populations described at the literature. Two variables differed from the literature: the high rate of HCC diagnosed at an early stage and with possibility of curative treatment and the greater percentage of cases diagnosed in asymptomatic patients. KEY WORDS: HEPATOCELLULAR, CARCINOMA; HEPATITIS C, CHRONIC/epidemiology; ALFA-FETOPROTEINS.Objetivos: Determinar o perfil dos pacientes com diagnóstico de carcinoma hepatocelular (CHC) associado à hepatopatia crônica pelo HCV no HSLPUCRS. Métodos: Estudo transversal de dados obtidos através da revisão de prontuários. Foram analisados num período de 24 meses os prontuários dos pacientes que tiveram alfa-fetoproteína dosada no Laboratório de Patologia Clínica do HSL. Incluídos aqueles que tiveram diagnóstico de CHC associado à infecção pelo HCV. Resultados: Foram identificados 28 casos de CHC relacionados à infecção pelo HCV. Todos os pacientes apresentavam evidências de hepatopatia crônica. Entretanto, 28,5% eram assintomáticos. O tipo não invasivo de diagnóstico foi empregado em 64,3% dos casos. O nível sérico da alfa-fetoproteína encontravase superior a 400 ng/mL em 67,8% dos pacientes. No exame de imagem 78,5% eram do tipo nodular e 57,1% se localizavam no lobo hepático direito. Em 25% o diagnóstico foi feito em estágio precoce, permitindo abordagem terapêutica com intenção curativa. Em metade dos pacientes nenhum tipo de tratamento específico contra o tumor foi empregado, por se tratar de neoplasia avançada. Conclusões: O perfil dos pacientes com CHC e hepatopatia crônica pelo HCV diagnosticados no HSL-PUCRS é semelhante ao de outras populações ocidentais descritas na literatura. Dois dados diferem da literatura: a alta percentagem de CHC diagnosticados ainda com possibilidade de tratamento com intenção curativa e a maior percentagem de casos diagnosticados em pacientes assintomáticos. DESCRITORES: CARCINOMA HEPATOCELULAR; HEPATITE C CRÔNICA/epidemiologia;ALFA-FETOPROTEÍNAS.Editora da PUCRS - ediPUCRS2007-12-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionEstudo transversalapplication/pdfapplication/pdfhttps://revistaseletronicas.pucrs.br/scientiamedica/article/view/1614Scientia Medica; Vol. 16 No. 4 (2006); 157-161Scientia Medica; v. 16 n. 4 (2006); 157-1611980-61081806-5562reponame:Scientia Medica (Porto Alegre. Online)instname:Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)instacron:PUC_RSporenghttps://revistaseletronicas.pucrs.br/scientiamedica/article/view/1614/1781https://revistaseletronicas.pucrs.br/scientiamedica/article/view/1614/7900Kupski, CarlosNarciso, Gustavo RigonMaggioni, Lucas SpadariNader, Lysandro Alsinainfo:eu-repo/semantics/openAccess2013-07-17T17:29:22Zoai:ojs.revistaseletronicas.pucrs.br:article/1614Revistahttps://revistaseletronicas.pucrs.br/scientiamedica/PUBhttps://revistaseletronicas.pucrs.br/scientiamedica/oaiscientiamedica@pucrs.br || editora.periodicos@pucrs.br1980-61081806-5562opendoar:2013-07-17T17:29:22Scientia Medica (Porto Alegre. Online) - Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)false |
dc.title.none.fl_str_mv |
Profile of the hepatocellular carcinoma in patients with diagnosis of chronic C hepatitis [Abstract in English] Perfil do carcinoma hepatocelular em pacientes portadores de hepatopatia crônica pelo vírus C |
title |
Profile of the hepatocellular carcinoma in patients with diagnosis of chronic C hepatitis [Abstract in English] |
spellingShingle |
Profile of the hepatocellular carcinoma in patients with diagnosis of chronic C hepatitis [Abstract in English] Kupski, Carlos CARCINOMA HEPATOCELULAR HEPATITE C CRÔNICA EPIDEMIOLOGIA ALFA-FETOPROTEÍNAS. |
title_short |
Profile of the hepatocellular carcinoma in patients with diagnosis of chronic C hepatitis [Abstract in English] |
title_full |
Profile of the hepatocellular carcinoma in patients with diagnosis of chronic C hepatitis [Abstract in English] |
title_fullStr |
Profile of the hepatocellular carcinoma in patients with diagnosis of chronic C hepatitis [Abstract in English] |
title_full_unstemmed |
Profile of the hepatocellular carcinoma in patients with diagnosis of chronic C hepatitis [Abstract in English] |
title_sort |
Profile of the hepatocellular carcinoma in patients with diagnosis of chronic C hepatitis [Abstract in English] |
author |
Kupski, Carlos |
author_facet |
Kupski, Carlos Narciso, Gustavo Rigon Maggioni, Lucas Spadari Nader, Lysandro Alsina |
author_role |
author |
author2 |
Narciso, Gustavo Rigon Maggioni, Lucas Spadari Nader, Lysandro Alsina |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Kupski, Carlos Narciso, Gustavo Rigon Maggioni, Lucas Spadari Nader, Lysandro Alsina |
dc.subject.por.fl_str_mv |
CARCINOMA HEPATOCELULAR HEPATITE C CRÔNICA EPIDEMIOLOGIA ALFA-FETOPROTEÍNAS. |
topic |
CARCINOMA HEPATOCELULAR HEPATITE C CRÔNICA EPIDEMIOLOGIA ALFA-FETOPROTEÍNAS. |
description |
Aims: To determine the profile of the patients with diagnosis of hepatocellular carcinoma (HCC) and chronic C hepatitis at HSL-PUCRS. Methods: Transversal study with data obtained from medical records. In a 24 months period the medical records of all patients who had alfa-fetoproteins dosed at HSL clinical pathology laboratory were reviewed. All those who had the diagnosis of HCC and HCV infection were included. Results: 28 cases of HCC associated with HCV infection were identified. All patients had signs of chronic hepatic disease. 28.5%, however, were asymptomatic at the time of diagnosis. A non invasive criterion for diagnosis was used in 64.3% of the patients. The serum dosage of alfa-fetoproteins was higher than 400 ng/mL in 67.8% of the patients and the combination of two image methods was used in 60.7%. 78.5% of the tumors were nodular and 57.1% located at the right lobe. In 25% the diagnosis was done at an early stage, with possibility of curative treatment. In half the patients no specific tumor treatment was indicated because they were staged as advanced disease. Conclusions: The profile of the patients with HCC and chronic HCV is similar to other occidental populations described at the literature. Two variables differed from the literature: the high rate of HCC diagnosed at an early stage and with possibility of curative treatment and the greater percentage of cases diagnosed in asymptomatic patients. KEY WORDS: HEPATOCELLULAR, CARCINOMA; HEPATITIS C, CHRONIC/epidemiology; ALFA-FETOPROTEINS. |
publishDate |
2007 |
dc.date.none.fl_str_mv |
2007-12-10 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Estudo transversal |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://revistaseletronicas.pucrs.br/scientiamedica/article/view/1614 |
url |
https://revistaseletronicas.pucrs.br/scientiamedica/article/view/1614 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://revistaseletronicas.pucrs.br/scientiamedica/article/view/1614/1781 https://revistaseletronicas.pucrs.br/scientiamedica/article/view/1614/7900 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Editora da PUCRS - ediPUCRS |
publisher.none.fl_str_mv |
Editora da PUCRS - ediPUCRS |
dc.source.none.fl_str_mv |
Scientia Medica; Vol. 16 No. 4 (2006); 157-161 Scientia Medica; v. 16 n. 4 (2006); 157-161 1980-6108 1806-5562 reponame:Scientia Medica (Porto Alegre. Online) instname:Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS) instacron:PUC_RS |
instname_str |
Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS) |
instacron_str |
PUC_RS |
institution |
PUC_RS |
reponame_str |
Scientia Medica (Porto Alegre. Online) |
collection |
Scientia Medica (Porto Alegre. Online) |
repository.name.fl_str_mv |
Scientia Medica (Porto Alegre. Online) - Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS) |
repository.mail.fl_str_mv |
scientiamedica@pucrs.br || editora.periodicos@pucrs.br |
_version_ |
1809101748440137728 |